TerrAscend Corp. (TSND.TO) Financials

TSND.TO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 766.2 million 639.3 million
Dec. 31, 2025 777.1 million 641.6 million
Sept. 30, 2025 773.2 million 640.2 million
June 30, 2025 778.3 million 617.2 million

TSND.TO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 10.5 million 1.2 million
Dec. 31, 2025 8.8 million 1.8 million
Sept. 30, 2025 619626 1.9 million
June 30, 2025 1.1 million 1.1 million

TSND.TO Net Income

No data available :(

TSND.TO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 55.1 million 295.8 million 41.2 million
Dec. 31, 2025 51.8 million 288.9 million 41.1 million
Sept. 30, 2025 52.2 million 295.1 million 44.2 million
June 30, 2025 37.6 million 270.9 million 43.9 million

TSND.TO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 430.2 million
Dec. 31, 2025 423.0 million
Sept. 30, 2025 426.5 million
June 30, 2025 406.9 million

TSND.TO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.2 million - 29.5 million -
Dec. 31, 2025 2.4 million - 31.7 million -
Sept. 30, 2025 3.1 million - 28.4 million 1.5 million
June 30, 2025 2.8 million - 27.6 million 1.2 million

TSND.TO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 89.9 million 44.6 million
Dec. 31, 2025 92.1 million 46.0 million
Sept. 30, 2025 90.6 million 43.4 million
June 30, 2025 88.4 million 43.2 million

TSND.TO

Price: CA$1

52 week price:
0.31
2.00

Payout Ratio Range:
-24.44%
10.82%

Earnings Per Share: -0.14 CAD

Exchange: TOR

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 332.0 million

Links: